DIGITAL EDITION

ARCHIVES

Category: Past Articles

Patient Challenges in Utilization of Methadone to Treat Opioid Use Disorder and Perspectives on a Solution for Improved Security and Convenience in Take-home Dosing

by Eric Morse, MD; Graeme Christianson, BSE; Melissa Olivadoti, PhD; and John Timberlake, MBA Dr. Morse is with Carolina Performance in Raleigh, North Carolina and Morse Clinics in Raleigh, North

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in the Geriatric Population

by Nitin Pothen, MD; Prachi Patel, BSN, MD; and Aneela Jafri, MD All authors are with Ocean University Medical Center in Brick, New Jersey. Funding: No funding was provided for

Outcome of Ischemic Stroke at Six Months with Neuroglobin as a Marker

by Yetty Ramli, MD, SpN(K); Fadhlan Rusdi, MD, SpN; Mohammad Kurniawan, MD, SpN(K); Mohamad Sadikin, MD, DSc; and Florencia Evelyn, MD Drs. Ramli, Rusdi, Kurniawan, and Evelyn are with the

Analysis of Levels of Vitamin D, Beta-Amyloid 42, Indoxyl Sulfate, and Serum Parathyroid Hormone in Hemodialysis Patients with Cognitive Impairment

by Prof. Yuliarni Syafrita, Sp.N(K); Harnavi Harun, Sp.PD-KGH, FINASIM; Restu Susanti, Sp.S(K) M. Biomed; and Syarif Indra, Sp.N(K) Prof. Syafrita and Drs. Susanti Indra are with the Department of Neurology,

Risk Management: Artificial Intelligence in Clinical Practice

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:

Letter to the Editor: Activation of the Serotonergic Neurotransmission is a Double-edged Sword in the Treatment of Burning Mouth Syndrome

Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of chronic pain of unknown cause, contradictions can arise; a drug for the treatment of a disease might be a cause

Study of Clinical Characteristics of Intellectual Disability in Morocco

by Houda Bekkari , PhD; Dr. Yousra Benmakhlouf, PhD; Prof. Naima Ghailani Nourouti, PhD; Prof. Amina Barakat, PhD; and Prof. Mohcine Bennani Mechita, PhD All authors are with Intelligent Automation

Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review

by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire, MD; Jayant Totlani, DO; Nathalie Murphy, MD; Sabrina Renteria, MD; Mohamed Salem, BS; Tiffany Chang, MS; Rasha Abdelsalam MD; Rida

Risk Management: Fires, Floods, Hurricanes, Oh My! The Importance of Disaster Planning

by Akemini “Kem” Isang, RN, JD Ms. Isang is a Senior Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article.

Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report

by Melissa Free, MD; Hena Choi, BA; and Ritika Baweja, MD Drs. Free and Baweja are with Department of Psychiatry and Behavioral Health, Penn State Health Milton S. Hershey Medical

GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide)

by Senthil Vel Rajan Rajaram Manoharan, MD, and Rohit Madan, MD Dr. Manoharan is with Huntsville Hospital/University of Alabama at Birmingham – Huntsville Campus in Huntsville, Alabama. Dr. Madan is